日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Sequential first-line treatment with nab-paclitaxel/gemcitabine and FOLFIRINOX in metastatic pancreatic adenocarcinoma: GABRINOX phase Ib-II controlled clinical trial

转移性胰腺腺癌一线序贯治疗方案:紫杉醇/吉西他滨联合FOLFIRINOX方案:GABRINOX Ib-II期对照临床试验

Assenat, E; de la Fouchardière, C; Portales, F; Ychou, M; Debourdeau, A; Desseigne, F; Iltache, S; Fiess, C; Mollevi, C; Mazard, T